ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,935Medicare Part D Prescriptions Filled, Including Refills

Rank: 104 out of 1454

$1.05M Total Retail Price of All Prescriptions

Rank: 78 out of 1454

715 Patients Receiving at Least One Drug in Part D
59%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 715 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

17% of this provider’s 715 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 9,018 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 669 327 S3 1 7
OMEPRAZOLE 621 350 2 3
LISINOPRIL 581 367 3 4
SIMVASTATIN 558 429 4 1
METFORMIN HCL 404 227 5 8
FUROSEMIDE 383 228 6 6
AMLODIPINE BESYLATE 378 295 7 2
LEVOTHYROXINE SODIUM 340 203 8 5
NEXIUM 275 112 9 23
TRAMADOL HCL 271 118 10 20
METOPROLOL TARTRATE 267 148 11 10
CITALOPRAM HBR 262 161 12 21
LOVASTATIN 247 140 13 39
GABAPENTIN 246 96 14 16
FLUTICASONE PROPIONATE 212 93 15 30
ZOLPIDEM TARTRATE 205 125 16 19
ATENOLOL 203 135 17 18
HYDROCHLOROTHIAZIDE 189 95 18 9
WARFARIN SODIUM 189 124 18 17
PROAIR HFA 189 60 18 56
POTASSIUM CHLORIDE 182 79 21 15
OXYCODONE HCL-ACETAMINOPHEN 180 45 S2 22 93
ATORVASTATIN CALCIUM 174 111 23 11
CYMBALTA 166 39 24 55
CYCLOBENZAPRINE HCL 161 58 R 25 59
TAMSULOSIN HCL 159 128 26 34
SERTRALINE HCL 159 82 26 26
GLIPIZIDE 146 101 28 62
SYNTHROID 145 106 29 25
CARVEDILOL 132 120 30 24
PLAVIX 130 93 31 45
METOPROLOL SUCCINATE 125 93 32 13
LOSARTAN POTASSIUM 124 64 33 14
PRAVASTATIN SODIUM 117 84 34 12
ENALAPRIL MALEATE 114 85 35 58
OPANA ER 110 20 S2 36 275
ISOSORBIDE MONONITRATE ER 109 63 37 46
CRESTOR 109 74 37 22
CLOPIDOGREL 106 74 39 32
GLIMEPIRIDE 106 74 39 33
ADVAIR DISKUS 105 33 41 47
PAROXETINE HCL 104 40 42 73
SPIRIVA 104 44 42 52
PANTOPRAZOLE SODIUM 102 72 44 31
PROMETHAZINE HCL 97 31 R 45 82
VENTOLIN HFA 97 55 45 112
BUSPIRONE HCL 94 43 47 176
CARISOPRODOL 93 12 R 48 123
AMITRIPTYLINE HCL 90 50 R 49 71
DICLOFENAC SODIUM 87 50 50 118
MORPHINE SULFATE ER 86 32 S2 51 181
LYRICA 85 16 52 103
ALLOPURINOL 82 62 53 28
FLUOXETINE HCL 82 23 53 72
DONEPEZIL HCL 79 46 55 29
MELOXICAM 78 46 56 37
LANTUS SOLOSTAR 71 15 57 79
ACTOS 71 46 57 90
TRAZODONE HCL 71 20 57 50
DIOVAN HCT 71 39 57 75
PREDNISONE 69 46 61 36
SYMBICORT 69 21 61 143
COMBIVENT 68 34 63 115
OXYCODONE HCL 66 21 S2 64 80
ROPINIROLE HCL 65 24 65 96
AZITHROMYCIN 61 36 66 42
TRIAMCINOLONE ACETONIDE 59 29 67 142
RANITIDINE HCL 59 26 67 43
POLYETHYLENE GLYCOL 3350 59 32 67 61
VENLAFAXINE HCL ER 58 53 70 105
SINGULAIR 57 0 71 83
ESCITALOPRAM OXALATE 56 14 72 78
BACLOFEN 56 16 72 146
CELEBREX 55 45 74 81
TIZANIDINE HCL 54 17 75 154
FLUCONAZOLE 54 24 75 160
OXYCODONE-ACETAMINOPHEN 53 27 S2 77 60
DILTIAZEM 24HR CD 52 43 78 76
DIOVAN 50 39 79 40
BENAZEPRIL HCL 50 44 79 57
LISINOPRIL-HYDROCHLOROTHIAZIDE 50 25 79 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.